Actinium Pharmaceuticals, Inc. (delaware) · AMEX:ATNM
Seth Sandesh received 1,780,874 Actinium Pharmaceuticals, Inc. (delaware) shares as an award (Form 4)
Traded Sep 2, 2026 · Filed Sep 4, 2026
On Sep 2, 2026, Seth Sandesh (Director, Chief Executive Officer) received 1,780,874 Actinium Pharmaceuticals, Inc. (delaware) shares as an award, leaving 1,965,355 shares. Filed Sep 4, 2026 (Form 4).
- Awarded
- 1,780,874 shares
- Holding after
- 1,965,355 shares
- Trading plan
- No
- Role
- Director, Chief Executive Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Sep 2, 2026 | Common Stock | Award | 753,600 | 938,081 | Direct | |
| Sep 2, 2026 | Common Stock | Award | 1,027,274 | 1,965,355 | Direct |
Source
Related
- Actinium Pharmaceuticals, Inc. (delaware)
- Seth Sandesh
- Actinium Pharmaceuticals, Inc. (delaware) shareholders
- Form 4 · David Matthew T · Oct 16, 2026
- Form 4 · Nicholson, C. David · Sep 4, 2026
- Form 4 · Almenoff June Sherie · Sep 4, 2026
- Form 4 · Shetty Ajit · Sep 4, 2026
- Form 4 · Steinhart Richard I · Sep 4, 2026